Santos da Silva Jorge's Form 4 filing
MoonLake Immunotherapeutics (MLTX) · filed Feb 23, 2024
- Accession no.
- 0001213900-24-016544
- Filed
- Feb 23, 2024
- Trade date
- Feb 21, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $62.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Santos da Silva JorgeCIK 0001920509 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −1,125 | $55.27 | −$62,178.75 | 3,106,429 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.